Raju Prasad is an Analyst focused on therapeutics at William Blair & Company, L.L.C. He joined the firm in March 2014. Dr. Prasad previously worked as a research associate at the University of North Carolina’s Gillings School of Global Public Health and as an independent consultant with the U.S. Environmental Protection Agency. Dr. Prasad has a degree in cell biology and neuroscience from Rutgers University, an M.S. degree in exercise physiology from the University of Delaware and a Ph.D. in environmental sciences and engineering from the University of North Carolina at Chapel Hill with a focus in genetic toxicology and mutagenesis.
Innovative New Cell and Gene Therapies Show Transformative Benefits
August 18, 2022
Several Readouts on Allogeneic Cell Therapy Expected in 2020
March 20, 2020
A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019